Molecular Imaging in Cancer
	Anna Moore Associate Professor in Radiology at Harvard Medical School Assistant in Cell Biology at Massachusetts General Hospital Department of Radiology, MGH

Dr. Moore received her Ph.D. in Bioorganic Chemistry from the Russian Academy of Sciences and came to the MGH in 1991. Her research interests have been focused primarily on the uptake and processing of targeted contrast agents for molecular imaging, first at the Center for Molecular Imaging Research at MGH and now at the Athinoula A. Martinos Center for Biomedical Imaging. She has been particularly interested in creating target-specific contrast agents that will be able to detect tumor tissue with high specificity and with low binding to other tissues using multimodal imaging. As her work progressed, Dr. Moore became interested in the application of these powerful molecular imaging detection tools to other health care issues. She began work aimed at the development of noninvasive target-specific molecular imaging probes for the detection of the early stages of Type 1 diabetes and non-invasive assessment of beta-cell mass. She has published several papers on molecular imaging in both cancer and diabetes in leading peer-reviewed journals and obtained multiple grant awards from NIH and private funds (American Diabetes Association, RSNA, Juvenile Diabetes Foundation). Dr. Moore is an Assistant Professor of Radiology and a head of a group studying molecular imaging approaches to non-invasive detection of pathogenic conditions as well as a response to therapeutic intervention. In her new position at the Athinoula A. Martinos Center for Biomedical Imaging, she hopes to apply molecular approaches to imaging pathologic and normal processes in the brain.

Speaking in the special symposium on Nanotechnology for Cancer Prevention, Diagnosis and Treatment.